Literature DB >> 35997960

Factors Underlying Racial Disparity in Utilization of Hepatitis C-Viremic Kidneys in the United States.

Kofi Atiemo1, Robin Baudier2, Rebecca Craig-Schapiro3, Kexin Guo3, Nikhilesh Mazumder3, Amanda Anderson2, Lihui Zhao3,4, Daniela Ladner3,5,6.   

Abstract

Utilization of hepatitis C (HCV) viremic kidneys is increasing in the United States. We examined racial disparity in this utilization using UNOS/OPTN data (2014-2020) and mixed effects models adjusting for donor/recipient/center factors. Included in the study were 58,786 adults receiving a deceased donor kidney transplant from 191 centers. Two thousand six hundred thirteen (4%) received kidneys from HCV-viremic donors. Of these, 1598 (61%) were HCV seronegative and 1015 (49%) were HCV seropositive. Among seronegative recipients, before adjusting for waiting time and education, Blacks (OR 0.69, 95%CI (0.60, 0.80)), Hispanics (OR 0.63, 95%CI (0.51, 0.79)), and Asians (OR 0.69, 95%CI (0.53, 0.90)) were less likely than Whites to receive HCV-viremic kidneys. In final models, effect of race was attenuated. Notably, shorter waiting time (OR 0.65, 95%CI (0.63, 0.67)) and increasing educational level (grade school less likely compared to high school OR 0.67, 95% CI (0.49, 0.92) and college more likely than high school (OR 1.16 95% CI (1.02, 1.31)) were associated with receipt of HCV-viremic kidneys. Among HCV-seropositive recipients, recipient race was not independently associated with receipt of HCV-viremic kidneys; however, centers with larger populations of Black waitlisted patients were more likely to utilize HCV-viremic kidneys (OR 1.71, 95%CI (1.20, 2.45)) compared to other centers. Our results suggest recipient race does not independently determine who receives HCV-viremic kidneys; however, other underlying factors including waiting time, education (among seronegative), and center racial mix (among seropositive) contribute to the current differential distribution of HCV-viremic kidneys among races.
© 2022. W. Montague Cobb-NMA Health Institute.

Entities:  

Keywords:  Disparity; Hepatitis C-viremic kidney; Race

Year:  2022        PMID: 35997960     DOI: 10.1007/s40615-022-01398-0

Source DB:  PubMed          Journal:  J Racial Ethn Health Disparities        ISSN: 2196-8837


  28 in total

1.  PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation.

Authors:  Debbie L Seem; Ingi Lee; Craig A Umscheid; Matthew J Kuehnert
Journal:  Public Health Rep       Date:  2013-07       Impact factor: 2.792

Review 2.  An update on donor-derived disease transmission in organ transplantation.

Authors:  M G Ison; M A Nalesnik
Journal:  Am J Transplant       Date:  2011-03-28       Impact factor: 8.086

3.  Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients.

Authors:  David S Goldberg; Peter L Abt; Emily A Blumberg; Vivianna M Van Deerlin; Matthew Levine; K Rajender Reddy; Roy D Bloom; Susanna M Nazarian; Deirdre Sawinski; Paige Porrett; Ali Naji; Richard Hasz; Lawrence Suplee; Jennifer Trofe-Clark; Anna Sicilia; Maureen McCauley; Midhat Farooqi; Caren Gentile; Jennifer Smith; Peter P Reese
Journal:  N Engl J Med       Date:  2017-04-30       Impact factor: 91.245

4.  Mortality after acute myocardial infarction in hospitals that disproportionately treat black patients.

Authors:  Jonathan Skinner; Amitabh Chandra; Douglas Staiger; Julie Lee; Mark McClellan
Journal:  Circulation       Date:  2005-10-25       Impact factor: 29.690

5.  Association of Kidney Transplant Center Volume With 3-Year Clinical Outcomes.

Authors:  Elizabeth M Sonnenberg; Jordana B Cohen; Jesse Y Hsu; Vishnu S Potluri; Matthew H Levine; Peter L Abt; Peter P Reese
Journal:  Am J Kidney Dis       Date:  2019-05-07       Impact factor: 8.860

6.  Perceived discrimination predicts longer time to be accepted for kidney transplant.

Authors:  Larissa Myaskovsky; Donna Almario Doebler; Donna M Posluszny; Mary Amanda Dew; Mark Unruh; Linda F Fried; Galen E Switzer; Sunghee Kim; Chung-Chou H Chang; Mohan Ramkumar; Ron Shapiro
Journal:  Transplantation       Date:  2012-02-27       Impact factor: 4.939

7.  Mistrust, misperceptions, and miscommunication: a qualitative study of preferences about kidney transplantation among African Americans.

Authors:  M W Wachterman; E P McCarthy; E R Marcantonio; M Ersek
Journal:  Transplant Proc       Date:  2015-03       Impact factor: 1.066

8.  Race, Risk, and Willingness of End-Stage Renal Disease Patients Without Hepatitis C Virus to Accept an HCV-Infected Kidney Transplant.

Authors:  Maureen McCauley; Adam Mussell; David Goldberg; Deirdre Sawinski; Rodolfo N Molina; Ricarda Tomlin; Sahil D Doshi; Peter Abt; Roy Bloom; Emily Blumberg; Sanjay Kulkarni; Gabriela Esnaola; Justine Shults; Carrie Thiessen; Peter P Reese
Journal:  Transplantation       Date:  2018-04       Impact factor: 4.939

9.  Trends in Discard of Kidneys from Hepatitis C Viremic Donors in the United States.

Authors:  Su-Hsin Chang; Massini Merzkani; Krista L Lentine; Mei Wang; David A Axelrod; Siddiq Anwar; Mark A Schnitzler; Jason Wellen; William C Chapman; Tarek Alhamad
Journal:  Clin J Am Soc Nephrol       Date:  2021-01-15       Impact factor: 8.237

10.  Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial.

Authors:  Christine M Durand; Mary G Bowring; Diane M Brown; Michael A Chattergoon; Guido Massaccesi; Nichole Bair; Russell Wesson; Ashraf Reyad; Fizza F Naqvi; Darin Ostrander; Jeremy Sugarman; Dorry L Segev; Mark Sulkowski; Niraj M Desai
Journal:  Ann Intern Med       Date:  2018-03-06       Impact factor: 51.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.